Skip to main content

Advertisement

SpringerLink
Log in

Cancer associated serum antigen (CASA) levels in patients with breast carcinoma and in 3 control groups without breast cancer

  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract.

We have examined the predictive value of measurements of CASA (Cancer Associated Serum Antigen) levels in patients with breast carcinoma. The measurement uses monoclonal antibodies that bind to an epitope on the polymorphic epithelial mucin. CASA levels were of less value compared with the levels of other tumor markers (CA 15-3, CA 549 and CEA) in the management of patients with early breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Gynecology and Obstetrics, , , , ,

    M. Meisel, J. Weise & W. Straube

  2. Department of Pathology, Ernst-Moritz-Arndt-University, Greifswald, Germany, , , , , , DE

    G. Schwesinger

Authors
  1. M. Meisel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Weise
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Schwesinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. Straube
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 21 October 1997 / Accepted: 20 January 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meisel, M., Weise, J., Schwesinger, G. et al. Cancer associated serum antigen (CASA) levels in patients with breast carcinoma and in 3 control groups without breast cancer. Arch Gynecol Obstet 261, 159–162 (1998). https://doi.org/10.1007/s004040050215

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004040050215

Search

Navigation